BioCatalyst

Pirtobrutinib, Venetoclax, Rituximab — catalyst calendar

1 verified catalyst event(s) referencing Pirtobrutinib, Venetoclax, Rituximab, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10 (month)
in 11d
ESTIMATED
 READOUT
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus V
Phase 3 · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
 Loxo Oncology, Inc. Pirtobrutinib, Venetoclax, Rituximab ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.